1.58
-1.86%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About JBM (Healthcare)
Its shares trade on HKEX under the ticker 2161.HK. It has been listed since 5 February 2021. In the fiscal year to 31 March 2026, it reported revenue of HK$834.6m and net income of HK$201.1m. At that date it held total assets of HK$1.76bn and shareholders' equity of HK$1.08bn.
JBM (Healthcare) Ltd. functions as an investment holding company. The company employs 305 full-time employees The company went IPO on 2021-02-05. The firm operates its business through three segments. The Proprietary Chinese Medicines segment mainly distributes over the counter (OTC) proprietary Chinese medicines and concentrated Chinese medicine granule (CCMG) products. The Consumer Healthcare Products segment primarily distributes proprietary medicines in the form of OTC. The Health and Wellness Products segment sales and distributes health and wellness products. The firm operates business in domestic and overseas markets such as Southeast Asia, Europe, and North America.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 5 Feb 2021
- Employees
- 305
- Website
- jbmhealthcare.com.hk ↗
Leadership
Pay as last reported
- Mr. Kwong Yip SumNon-Executive Chairman of the BoardHK$18,000
- Mr. Yat Wai WongChief Executive Officer, Executive Director, since 2020HK$2.2m
- Mr. Kau Lap LamVice President - Finance
- Mr. Ka Kin WongVice President - Greater China Sales and E-commerce
- Ms. Lin WangDeputy General Manager - Proprietary Chinese Medicine Business
- Dr. Heung Kwan ChengExecutive Director, since 2024
- Ms. Hoi Ki LeungOperation Manager - Proprietary Chinese Medicine
- Ms. Chui Yee LoSenior Marketing Manager
- Mr. Chun Kau YuCompany Secretary
- Mr. Kwok Chun YeungNon-Executive DirectorHK$180,000
- Mr. Chun Leung YimNon-Executive DirectorHK$18,000
- Mr. Kam Chiu ChanIndependent Non-Executive DirectorHK$180,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- JBM (Healthcare) Ltd. distributes OTC proprietary Chinese medicines in Southeast Asia markets.
- The company's Consumer Healthcare Products segment covers OTC proprietary medicines globally.
- Health and Wellness Products segment targets North America and Europe markets effectively.
Weaknesses
- JBM (Healthcare) Ltd. has only 305 employees for its global operations.
- The company's business is limited to three segments without diversification.
- JBM (Healthcare) Ltd. operates in the pharmaceuticals sector with high regulatory challenges.
Opportunities
- Expanding OTC proprietary Chinese medicines in Southeast Asia markets presents growth potential.
- Growing demand for health and wellness products in North America offers new opportunities.
- Increasing consumer healthcare needs in Europe can drive segment expansion.
Threats
- Regulatory challenges in the pharmaceuticals sector may hinder market access.
- Competition in the OTC proprietary medicines segment could impact market share.
- Economic fluctuations in North America might affect health and wellness product sales.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.